Transferrin (TF), a biodegradable, non-immunogenic, non-toxic, iron-transporting protein can be used as a targeting ligand to enhance the delivery of TQ into non-small cell lung carcinoma (NSCLC) cells, a lethal cancer with few treatment options. Here, TF is linked to non-small cell lung carcinoma.